FDA Approves Bausch + Lomb, Novaliq Dry Eye Disease Drug

FDA Approves Bausch + Lomb, Novaliq Dry Eye Disease Drug

Source: 
BioSpace
snippet: 

Thursday, the FDA approved Bausch + Lomb and Novaliq’s perfluorohexyloctane ophthalmic solution, now to be marketed as Miebo, to treat symptoms of dry eye disease.